ESSEPNA
ESSEPNA
Approved
DIN Number
02510324
Drug Class
Human
Market Date
Jan 25, 2023
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02510324
AIG Number1662682001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BA01 AMINO ACIDS
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:20.00
Health Canada Classification
ACTIVE INGREDIENTS (16)
ALANINEActive
Strength: 1.4 G / 100 ML
Monograph: ALANINE
ARGININEActive
Strength: 1.2 G / 100 ML
Monograph: ARGININE
GLYCINEActive
Strength: 1.1 G / 100 ML
Monograph: GLYCINE
HISTIDINEActive
Strength: 0.3 G / 100 ML
Monograph: HISTIDINE
ISOLEUCINEActive
Strength: 0.5 G / 100 ML
Monograph: ISOLEUCINE
LEUCINEActive
Strength: 0.74 G / 100 ML
Monograph: LEUCINE
LYSINE (L-LYSINE ACETATE)Active
Strength: 0.66 G / 100 ML
Monograph: LYSINE (L-LYSINE ACETATE)
METHIONINEActive
Strength: 0.43 G / 100 ML
Monograph: METHIONINE
PHENYLALANINEActive
Strength: 0.51 G / 100 ML
Monograph: PHENYLALANINE
PROLINEActive
Strength: 1.12 G / 100 ML
Monograph: PROLINE
SERINEActive
Strength: 0.65 G / 100 ML
Monograph: SERINE
TAURINEActive
Strength: 0.1 G / 100 ML
Monograph: TAURINE
THREONINEActive
Strength: 0.44 G / 100 ML
Monograph: THREONINE
TRYPTOPHANActive
Strength: 0.2 G / 100 ML
Monograph: TRYPTOPHAN
TYROSINEActive
Strength: 0.04 G / 100 ML
Monograph: TYROSINE
VALINEActive
Strength: 0.62 G / 100 ML
Monograph: VALINE